GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$1.32M
Contract actions68
Awards / PIIDs45
Federal customers1
Contracting offices4
Average action$19.5K
Active fiscal years7
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $1.32M in net contract obligations to PHARMARON, INC across 68 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

PHARMARON, INC contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$4.9K
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$257.3K41
FY 2020$93.7K81−63.6%
FY 2021$327.4K131+249.6%
FY 2022$174.5K131−46.7%
FY 2023$231.6K231+32.7%
FY 2024$235.5K51+1.7%
FY 2025$4.9K21−97.9%

04 / Federal Customers

Which federal agencies buy from PHARMARON, INC?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
7529$1.32M68100.0%

05 / Contracting Offices

Which contracting offices buy from PHARMARON, INC?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
541380TESTING LABORATORIES$1.23M53192.7%
621511MEDICAL LABORATORIES$102.3K217.7%
541990ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES$28.6K612.2%
325412PHARMACEUTICAL PREPARATION MANUFACTURING$24.6K111.9%
325199ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING$12.8K111.0%
325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING$11.9K210.9%
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$10.0K210.8%
325998ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING-$93.2K11-7.0%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
Q301MEDICAL- LABORATORY TESTING$995.0K56175.1%
B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL$289.8K6121.9%
R499SUPPORT- PROFESSIONAL: OTHER$17.3K311.3%
6810CHEMICALS$12.8K111.0%
6505DRUGS AND BIOLOGICALS$10.0K210.8%

08 / Competition Pattern

How was PHARMARON, INC’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Other / unknown$1.03M29
Competed under SAP$475.1K24
Competed-$84.0K14
Not competed-$93.2K1

09 / Recent Contract Awards

What contract actions were recorded most recently for PHARMARON, INC?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75N95C25P00108Sep 25, 2025$10.7KNATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NCATS541380Q301

10 / Interpreting the Profile

How should you evaluate PHARMARON, INC as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.